Calcium Channel Blocker News and Research

RSS
Diuretic-based antihypertensive therapy touted for obese

Diuretic-based antihypertensive therapy touted for obese

Diuretic-based antihypertensive therapy touted for obese

Diuretic-based antihypertensive therapy touted for obese

BMI may influence which blood pressure treatments work best

BMI may influence which blood pressure treatments work best

Oil blend plus antihypertensive lowers blood pressure, cholesterol level

Oil blend plus antihypertensive lowers blood pressure, cholesterol level

Top line results from Zalicus Synavive Phase 2b study in rheumatoid arthritis

Top line results from Zalicus Synavive Phase 2b study in rheumatoid arthritis

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

PD risk factors for potential clinical screening identified

PD risk factors for potential clinical screening identified

Positive results from Zalicus Z944 Phase 1 SAD clinical study for chronic inflammatory pain

Positive results from Zalicus Z944 Phase 1 SAD clinical study for chronic inflammatory pain

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Doctors continue to prescribe dangerous nifedipine drug to elderly patients

Doctors continue to prescribe dangerous nifedipine drug to elderly patients

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

Zalicus fourth quarter revenue decreases to $8.2 million

Zalicus fourth quarter revenue decreases to $8.2 million

Zalicus completes reformulated Z160 Phase 1 clinical trial for pain

Zalicus completes reformulated Z160 Phase 1 clinical trial for pain

FDA accepts Tau Therapeutics' mibefradil IND for treatment of cancer

FDA accepts Tau Therapeutics' mibefradil IND for treatment of cancer

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

Zalicus commences Z160 Phase 1 clinical trial for pain

Zalicus commences Z160 Phase 1 clinical trial for pain

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic pain

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic pain

Convergence initiates CNV2197944 Phase I study in chronic pain

Convergence initiates CNV2197944 Phase I study in chronic pain

New discovery holds promise for TB treatment

New discovery holds promise for TB treatment

Preclinical data of Zalicus sodium channel compound published in journal PAIN

Preclinical data of Zalicus sodium channel compound published in journal PAIN